常潤股份(603201.SH):泰國生產基地已批量投產並承接對美出口訂單
格隆匯4月22日丨常潤股份(603201.SH)在互動平臺表示,公司爲提升市場抗風險能力,近年來持續推進海外產能建設佈局,公司泰國生產基地已批量投產並承接對美出口訂單,公司將綜合利用泰國生產基地積極開展對美出口業務、加強新興市場開拓、加強內部精細化管理以及降本增效、提升效率等一系列措施,應對關稅挑戰,維持公司穩健發展。公司將持續打造泰國生產基地的多品類、全產業鏈的產品線,加強海外產能佈局建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.